PEAK6 Group’s BioTelemetry BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-26,367
Closed -$1.05M – 5359
2018
Q1
$819K Buy
26,367
+4,297
+19% +$141K ﹤0.01% 2135
2017
Q4
$660K Buy
22,070
+20,381
+1,207% +$590K ﹤0.01% 2253
2017
Q3
$56K Buy
+1,689
New +$58.5K ﹤0.01% 3980
2016
Q3
– Sell
-15,759
Closed -$297K – 5107
2016
Q2
$257K Buy
+15,759
New +$232K ﹤0.01% 2956
2014
Q3
– Sell
-1,619
Closed -$12K – 5687
2014
Q2
$12K Buy
+1,619
New +$12.9K ﹤0.01% 4410
2013
Q4
– Sell
-24,104
Closed -$239K – 6027
2013
Q3
$239K Sell
24,104
-3,046
-11% -$24K ﹤0.01% 3530
2013
Q2
$160K Buy
+27,150
New +$91.4K ﹤0.01% 3810

Other funds holding BEAT

PEAK6 Group's BEAT Position: Q2 2018 in Review

PEAK6 Group sold out of BioTelemetry (BEAT) in Q2 2018, closing a stake of 26,367 shares — an estimated $1.05M sold.

PEAK6 Group first reported a position in BEAT in Q2 2013 and held it in 7 quarters. The position peaked at $819K in Q1 2018. 226 funds tracked by Wall St. Rank hold BEAT as of Q2 2018.

  • PEAK6 Group reported no remaining BioTelemetry position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 26,367 BioTelemetry shares in Q2 2018, an estimated $1.05M.
  • PEAK6 Group first reported a position in BioTelemetry in Q2 2013 and held it in 7 quarters.
  • PEAK6 Group's BioTelemetry position peaked at $819K in Q1 2018.
  • 226 funds tracked by Wall St. Rank held BioTelemetry as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.